Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline (Q33723738)

28 July 2017

Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

28 July 2017

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Aristidis Tsatsakis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Dimitrios Spandidos

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Nikolaos Drakoulis

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Ramona Cioboată

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Alice Găman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Diana Traşcă

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Anca Ungureanu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Paul Tomescu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Florin Gherghina

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Andreea Letitia Arsene

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Corin Badiu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Daniela Călina

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

23 March 2017

1 reference

Experimental and Therapeutic Medicine

28 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

2375-2381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

NAFLD leads to liver cancer: do we have sufficient evidence?

12 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Pesticide exposure and genetic variation in xenobiotic-metabolizing enzymes interact to induce biochemical liver damage

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Histopathological lesions, oxidative stress and genotoxic effects in liver and kidneys following long term exposure of rabbits to diazinon and propoxur.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Statins for the primary prevention of cardiovascular disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Nonalcoholic fatty liver disease and its association with cardiovascular disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Metabolic syndrome and non-alcoholic fatty liver disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Review article: Drug therapy for non-alcoholic fatty liver disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Tumour necrosis factor alpha: a key regulator of adipose tissue mass

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Environmental pollution: a tangible risk for NAFLD pathogenesis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443168

Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis

30 October 2018

1 reference

12 December 2020

A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients

1 reference

12 December 2020

Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells

1 reference

12 December 2020

TNF-alpha as therapeutic target in NASH: tried, but not yet proven

1 reference

12 December 2020

Identifiers

DOI

10.3892/ETM.2017.4256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28565851%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference